Clinical and Translational Cancer Control Research Training Program
The National Cancer Institute (NCI) supported Cancer Control Research Training Program at the University of Rochester School of Medicine, located in the beautiful Finger Lakes Region of upstate New York, is now in its 23rd year and provides post-doctoral M.D. or Ph.D. researchers with the knowledge and experience to establish careers as outstanding independent investigators in cancer control and prevention research.
University of Rochester NCI-Funded T32
Cancer Control Research Training Program Achievements
- 51 total fellows over 23 years.
- 42 graduates are currently in tenure-track faculty positions at 21 unique academic institutions; 4 are in industry. (The remaining fellows are still in training or starting this summer.)
- 90% of our fellows remained in academia.
- 72% of fellows are now Associate/Full Professor.
- Over $100M total in NIH research grants awarded to fellows as PIs.
- 24 K awards and 12 other career development grants awarded to fellows.
- 95% success rate of eligible fellows awarded Loan Repayment Program grants.
Features of the program include:
- An emphasis on transdisciplinary clinical and translational research and resources to take advantage of opportunities to conduct cancer control research both locally and nationally.
- Exceptionally diverse research opportunities and professional guidance and mentorship provided by our NCI-funded Core Mentors and 15 other on-site mentors who all hold competitively funded cancer-related research grants. Mentorship opportunities are also provided by offsite mentors involved in the University of Rochester NCI-funded Community Oncology Research Program Research Base.
- Programmatic specialty areas include training in: conduct of clinical trials (Phase I through III) in both academic and community settings through the University of Rochester NCI-funded Community Oncology Research Program Research Base, geriatric oncology and cancer care delivery research, exercise oncology,translational research, and biostatistics.
- Practical experience in protocol design, study procedures, statistical analysis, manuscript writing and oral presentation.
- An emphasis on preparation for successfully obtaining research funding.
- A choice of earning one of five advanced Master of Science (MS) degrees, uniquely tailored to methodologies necessary to successful execution of research interests of the trainee.
- Curriculum, seminars and workshops on cancer control and research methodology in three focus areas: patient-oriented research, health outcomes research, and biostatistics and informatics research.
- Special courses and seminars developed specifically for cancer control issues.
- Opportunities for scientific and professional networking at 3 scientific meetings per year, cooperative oncology group meetings and mini-sabbaticals.
- Support for pilot studies leading to career development proposals.
- MPI directorship by Drs. Janelsins and Peppone fostering collaboration and multidisciplinary research, within a culture of mentoring.
Candidate Selection Criteria
The Clinical and Translational Cancer Control Research Training Program seeks individuals with recent doctorates (Ph.D., Dr.P.H., M.D.) in health-related areas and who are highly motivated to develop a successful research career in cancer control.
Candidates must be United States citizens or permanent residents. Two years of funding with stipends of $70,000 per year are offered along with tuition, health insurance, childcare costs, research support, travel to up to three scientific meetings per year and an appointment as a Research Assistant Professor. The position will begin during the Summer of 2027.
How to Apply
Applicants please submit:
- A curriculum vitae
- A statement of your interest telling specifically how this program would help you get from where you are to where you want to be professionally (a convincing section on your passion for research is a definite plus)
- Three signed academic letters of support (have them sent to you and include them with the other two required items when you submit the completed application)
Submit by Email
Please email Drs. Janelsins and Peppone with copy to Kate Kessler:
Dr. Michelle Janelsins
Dr. Luke Peppone
Program Directors of the Clinical and Translational Cancer Control Research Training Program
Kate Kessler
Program Coordinator of the Cancer Control Research Training Program
Email: cancercontrolT32@urmc.rochester.edu
Submit by Mail
Clinical and Translational Cancer Control Research Training Program
Attn: Kate Kessler
265 Crittenden Blvd.
Box 658
Rochester, NY 14642
Phone: (585) 275-5513
Fax: (585) 461-5601